Format

Send to

Choose Destination
Sci Rep. 2018 Jan 16;8(1):862. doi: 10.1038/s41598-018-19262-9.

Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice.

Author information

1
North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, 76107, United States.
2
North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, 76107, United States. abe.clark@unthsc.edu.

Abstract

Prolonged glucocorticoid (GC) therapy can cause GC-induced ocular hypertension (OHT), which if left untreated progresses to iatrogenic glaucoma and permanent vision loss. The alternatively spliced isoform of glucocorticoid receptor GRβ acts as dominant negative regulator of GR activity, and it has been shown that overexpressing GRβ in trabecular meshwork (TM) cells inhibits GC-induced glaucomatous damage in TM cells. The purpose of this study was to use viral vectors to selectively overexpress the GRβ isoform in the TM of mouse eyes treated with GCs, to precisely dissect the role of GRβ in regulating steroid responsiveness. We show that overexpression of GRβ inhibits GC effects on MTM cells in vitro and GC-induced OHT in mouse eyes in vivo. Ad5 mediated GRβ overexpression reduced the GC induction of fibronectin, collagen 1, and myocilin in TM of mouse eyes both in vitro and in vivo. GRβ also reversed DEX-Ac induced IOP elevation, which correlated with increased conventional aqueous humor outflow facility. Thus, GRβ overexpression reduces effects caused by GCs and makes cells more resistant to GC treatment. In conclusion, our current work provides the first evidence of the in vivo physiological role of GRβ in regulating GC-OHT and GC-mediated gene expression in the TM.

PMID:
29339763
PMCID:
PMC5770444
DOI:
10.1038/s41598-018-19262-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center